Heterozygous Familial Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Heterozygous Familial Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-11-21FDA Approved: NEXLIZET — Supplemental Application (Esperion Therapeutics, Inc.)
FDA approved a supplemental application for NEXLIZET (bempedoic acid and ezetimibe) to update/expand its labeling.